| Absorption | 
      | Blood-Brain Barrier | BBB- | 0.9918 | 
      | Human Intestinal Absorption | HIA- | 0.9213 | 
      | Caco-2 Permeability | Caco2+ | 0.8867 | 
      | P-glycoprotein Substrate | Substrate | 0.5543 | 
      | P-glycoprotein Inhibitor | Non-inhibitor | 0.9052 | 
                                                     | Non-inhibitor | 0.9543 | 
      | Renal Organic Cation Transporter | Non-inhibitor | 0.9423 | 
        
            | Distribution | 
        
      | Subcellular localization | Lysosome | 0.6219 | 
        
          | Metabolism | 
        
      | CYP450 2C9 Substrate | Non-substrate | 0.8983 | 
      | CYP450 2D6 Substrate | Non-substrate | 0.8513 | 
      | CYP450 3A4 Substrate | Non-substrate | 0.5094 | 
      | CYP450 1A2 Inhibitor | Non-inhibitor | 0.9045 | 
      | CYP450 2C9 Inhibitor | Non-inhibitor | 0.9071 | 
        | CYP450 2D6 Inhibitor | Non-inhibitor | 0.9231 | 
      | CYP450 2C19 Inhibitor | Non-inhibitor | 0.9026 | 
      | CYP450 3A4 Inhibitor | Inhibitor | 0.7960 | 
      | CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.9283 | 
        
          | Excretion | 
        
        
          | Toxicity | 
        
      | Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9996 | 
                                                                    | Non-inhibitor | 0.8150 | 
      | AMES Toxicity | Non AMES toxic | 0.8164 | 
      | Carcinogens | Non-carcinogens | 0.6461 | 
      | Fish Toxicity | High FHMT | 0.9666 | 
      | Tetrahymena Pyriformis Toxicity | High TPT | 0.9226 | 
      | Honey Bee Toxicity | Low HBT | 0.6107 | 
      | Biodegradation | Not ready biodegradable | 0.9769 | 
      | Acute Oral Toxicity | IV | 0.6130 | 
      | Carcinogenicity (Three-class) | Non-required | 0.6503 |